XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE - Revenue from Commercialization Agreement (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues   $ 57,203 $ 63,274 $ 115,132 $ 191,678
Royalties and milestones          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues   263 5,257 886 5,507
Revenue From Transfer Of Inventory From Commercialization Agreement          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues   0 0 0 55,705
Commercialization Agreement And Amended Commercialization Agreement | Collegium Pharmaceutical Inc          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues   31,000   61,900  
Commercialization Agreement And Amended Commercialization Agreement | Collegium Pharmaceutical Inc | Royalties and milestones          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues   31,900 $ 31,200 64,000 $ 59,300
Expense related to third-party royalties   $ (1,000)   $ (2,100)  
Performance Obligation Transfer Of Finished Goods | Collegium Pharmaceutical Inc | Revenue From Transfer Of Inventory From Commercialization Agreement          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Total revenues $ 55,700